AB2 Bio signs U.S. option and licensing agreement with Nippon Shinyaku for Tadekinig alfa for an ultra-rare autoimmune disease
January 27, 2025 02:30 ET
|
AB2 Bio Ltd
Agreement grants Nippon Shinyaku an option to acquire exclusive U.S. rights to commercialize AB2 Bio’s Tadekinig alfa to treat Primary Monogenic IL-18 driven Hyperinflammatory Syndrome in patients...
Persephone Biosciences Announces First Subject Enrolled in ARTEMIS Clinical Trial of New Infant Synbiotic
January 23, 2025 09:00 ET
|
Persephone Biosciences, Inc.
Persephone Biosciences Announces First Subject Enrolled in ARTEMIS Clinical Trial of New Infant Synbiotic
New Clinical Trial of eTNS for Pediatric ADHD to Commence at Denmark’s Center for Evidence-Based Psychiatry
December 11, 2024 09:00 ET
|
NeuroSigma, Inc.
LOS ANGELES, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for Evidence-Based Psychiatry (CEBP) in Denmark has...
[Latest] Global Acute Respiratory Infection Market Size/Share Worth USD 20,796.6 Billion by 2033 at a 1.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
October 29, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Acute Respiratory Infection Market Size, Trends and Insights By Drug Type...
Lighthouse Autism Center Announces Expansion of ABA Services in Iowa
September 24, 2024 09:00 ET
|
Lighthouse Autism Center
Lighthouse Autism Center is expanding its ABA services with a new center in Cedar Rapids, IA, set to open in late 2024. This will be their sixth IA center.
Key Highlights of Lighthouse Fusion
August 27, 2024 09:00 ET
|
Lighthouse Autism Center
Lighthouse Autism Center expands its speech therapy program with more dually certified SLPs and BCBAs, offering better outcomes for children with autism.
Medical Education Market is Projected to Expand at 5.1% CAGR, Reaching US$ 57.95 Billion by 2034 | Fact.MR
August 19, 2024 07:00 ET
|
FACT.MR
Rockville, MD, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Revenue from medical education is estimated to reach US$ 35.11 billion in 2024, as revealed in a study recently updated by Fact.MR, a market research...
Lighthouse Autism Center Partners with Local Government Officials to Highlight Autism Services and Community Impact
August 16, 2024 09:00 ET
|
Lighthouse Autism Center
Lighthouse Autism Center partners with local officials to boost autism awareness and support, with visits in several cities to highlight services.
ConSynance Therapeutics Announces U.S. FDA Grants Rare Pediatric Disease Designation to CSTI-500, a Potential First-in-Class Therapy for Prader-Willi Syndrome
July 24, 2024 10:00 ET
|
ConSynance Therapeutics
FDA awards ConSynance's CSTI-500 Rare Pediatric Disease Designation for innovative Prader-Willi Syndrome treatment.
Global Continuing Medical Education Market to Reach USD 18.45 billion by 2032, Experiencing Steady Growth at a 7.72% CAGR | Straits Research
July 04, 2024 09:35 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, July 04, 2024 (GLOBE NEWSWIRE) -- As per the latest report by Straits Research, the global continuing medical education market size was valued at USD 9.45 billion in 2023....